Home The foundation Research Studies and research Simeprevir

Named Patient/Compassionate Use Program of Simeprevir in patients with chronic genotype 1 or 4 HCV infection who are clinically compensated (Child Pugh A or B), ineligible to receive IFN and have not undergone liver transplantation

                                                                                                                                                                                                                 

Study description

Questo programma "Named Patient" / Uso Compassionevole fornisce accesso prematuro a Simeprevir per i pazienti con infezione da HCV che non hanno altre opzioni di trattamento medico praticabili.

Pathology

Hepatitis C Virus HCV

Study type

Clinical trial

Status

Terminated

Study start date

2014

Study completion date

2016

Funder Type

Industry funded study

Investigator

Dr. med. Lorenzo MAGENTA

Recruitment

Completed

Learn more

ClinicalTrials.gov